Close

More on ARRY

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-116.0% Growth)
- Ratings (5.7 Score)
- Holders
- Event Driven Deals
- FDA Archive

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (5/9/24)
- M&A (12/31/19 *Est)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

ARRY Balance Sheet

Click line-items for a historical chart and %
Current assets
Cash and cash equivalents 65.84M
Marketable securities
Prepaid expenses and other current assets 7.43M
Total current assets 158.02M
Long-term assets
Marketable securities
Property and equipment, net 7.25M
Other long-term assets 929K
Total long-term assets 8.84M
Total assets 166.86M
Current liabilities
Accounts payable 5.92M
Accrued outsourcing costs 25.55M
Accrued compensation and benefits 10.15M
Other accrued expenses 1.94M
Deferred rent 596K
Deferred revenue 9.85M
Current portion of long-term debt
Total current liabilities 64.21M
Long-term liabilities
Deferred rent 4.46M
Deferred revenue 34.3M
Long-term debt, net 115.35M
Derivative liabilities
Other long-term liabilities 662K
Total long-term liabilities 154.77M
Total liabilities 218.99M
Commitments and contingencies 0
Stockholders' deficit
Common stock, $0.001 par value; 120,000,000 shares authorized; 57,051,053 and 57,020,003 shares issued and outstanding, as of September 30, 2011 and June 30, 2011 respectively 147K
Additional paid-in capital
Warrants
Accumulated other comprehesive income (loss) 11K
Accumulated deficit -830.02M
Total stockholders' deficit -52.12M
Total liabilities and stockholders' deficit 166.86M
Series A junior participating convertible preferred stock
Stockholders' deficit
Preferred stock 0
Series B convertible preferred stock
Stockholders' deficit
Preferred stock